[Neuropsychological changes in epilepsy].
OBJECTIVE
The neuropsychological assessment of the epileptic patient is a very important aspect of diagnosis and treatment. It may be used to contribute to localization of the hemisphere involved in the seizures, differentiate situations of anxiety or depression or when planning treatment for rehabilitation. We review the different aspects of neuropsychological changes in patients with epilepsy.


METHODS
Firstly we review the different tests used in the neuropsychological assessment of epilepsy. Dodrill's neuropsychological battery of tests, in which the patients score less than the controls, is the most commonly used. We then evaluate and study the so-called 'transient cognitive disorder'. We also study memory problems in epilepsy. There may be episodes of seizures with amnesic features ('amnesic epileptic seizures'). Finally, the possibility of neuropsychological dysfunction secondary to antiepileptic drugs should always be considered.


CONCLUSIONS
Epileptic patients have lower scores than persons taken as controls for the results of various neuropsychological tests, although there is less difference between the two groups when the patient group is made up of persons with a normal intelligence quotient. Transient cognitive involvement is common in epileptics and may cause underachievement at school or psychological problems. Memory disorders, particularly subjective, are common in epileptics, although neuropsychological tests other than those generally used may be necessary to evaluate this. It is possible that such memory disorders, if occurring as seizures, may be due to amnesic partial crises, which should always be differentiated from the diagnosis of transient global amnesia. Almost all antiepileptic drugs can cause negative neuropsychological effects, especially the benzodiazepines and barbiturates.
Mauri-Llerda
J A
JA
Servicio de Neurología, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España. jamauri@retemail.es
Pascual-Millán
L F
LF
Tejero-Juste
C
C
Iñiguez
C
C
Escalza-Cortina
I
I
Morales-Asín
F
F
D000208:Acute Disease; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D003072:Cognition Disorders / Q000139:chemically induced / Q000175:diagnosis / Q000209:etiology; D004569:Electroencephalography; D004827:Epilepsy / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology*; D006801:Humans; D008569:Memory Disorders / Q000209:etiology; D009483:Neuropsychological Tests; D013577:Syndrome
D000927:Anticonvulsants